Get started
Author

Hunter Lambert

Observed name: J Hunter Lambert
ORCID: 0000-0002-4212-0671
Observed ORCID: 0000-0002-4212-0671
OpenAlex ID: A5032959916
Antiemetic use and chemotherapy induced nausea and vomitingrelated hospitalization costs after highly or moderately emetogenic chemotherapy
2023 · Winnie W Nelson, Varun Vaidya, et al. · Future Oncology · 11
Daratumumab Utilization and Cost Analysis among Patients with Multiple Myeloma in a US Community Oncology Setting
2021 · Lucio N Gordan, Stanley M Marks, et al. · Future Oncology · 10
Abstract WE486: Cost-Effective Analysis of a Louisiana Community Program Addressing Food Insecurity
2026 · Hunter Lambert, patrick bernet, et al. · Circulation
MPN-453 Clinical Presentation and Diagnosis of Advanced Systemic Mastocytosis (AdvSM) in a Community Oncology Setting
2022 · Erin Sullivan, Charlie Daddona, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: MPN-453 Clinical Presentation and Diagnosis of Advanced Systemic Mastocytosis (AdvSM) in a Community Oncology Setting
2022 · Erin Sullivan, Charlie Daddona, et al. · Clinical Lymphoma Myeloma & Leukemia
HSR21-047: Tumor Lysis Syndrome Risk Analysis in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network
2021 · Kaustav Chatterjee, Edward Drea, et al. · Journal of the National Comprehensive Cancer Network
Daratumumab Dose Analysis Among Patients with Multiple Myeloma in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network
2020 · Robert E Smith, Mei Xue, et al. · Blood
Works count: 7
Citation count: 21
H-index: 2
I10-index: 2
Year
Topic
Type